Home
AMRN
AMRN News

Latest Amarin Corporation plc (AMRN) News on June 25, 2025

MT Newswires

a day ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

a day ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

MT Newswires

a day ago

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires

a day ago

Update: Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe; Shares Rise

MT Newswires

a day ago

Amarin Signs Licensing Deal With Recordati for Vazkepa in Europe

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE

GlobeNewswire

a day ago

RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA® IN EUROPE

Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe

GlobeNewswire

a day ago

Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma

Zacks

6 days ago

Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?

Zacks

9 days ago

Amarin (AMRN) Now Trades Above Golden Cross: Time to Buy?

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Zacks

9 days ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Zacks

15 days ago

Amarin (AMRN) Upgraded to Strong Buy: What Does It Mean for the Stock?

Best Momentum Stocks to Buy for June 10th

Zacks

15 days ago

Best Momentum Stocks to Buy for June 10th

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?

Zacks

a month ago

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year?

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall St.

2 months ago

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Boosting Their Estimates

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y

Zacks

2 months ago

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y

Amarin First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

2 months ago

Amarin First Quarter 2025 Earnings: Misses Expectations

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...

GuruFocus.com

2 months ago

Amarin Corp PLC (AMRN) Q1 2025 Earnings Call Highlights: Strategic Global Expansion Amidst ...

Associated Press Finance

2 months ago

Amarin: Q1 Earnings Snapshot

Amarin Reports First Quarter 2025 Financial Results

GlobeNewswire

2 months ago

Amarin Reports First Quarter 2025 Financial Results

GuruFocus.com

2 months ago

Standex International Corp (SXI) Q3 2025 Earnings Call Highlights: Record Margins and Strategic ...

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

2 months ago

Amarin Regains Compliance with Nasdaq Minimum Bid Price Requirement

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

GlobeNewswire

2 months ago

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

GlobeNewswire

3 months ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors

GlobeNewswire

3 months ago

Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist

GlobeNewswire

3 months ago

Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist

MT Newswires

3 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

3 months ago

Amarin Shareholders Calls for Strategic Review

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

GlobeNewswire

3 months ago

New Research Exploring Mechanistic Benefits of Eicosapentaenoic Acid (EPA) In Vitro on Lipoprotein(a) [Lp(a)] Oxidation and on Protein Expression in Endothelial Cells in Combination with GLP-1 Receptor Agonist to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan

Zacks

3 months ago

AMRN's Q4 Earnings Lag Estimates, Stock Down on Ratio Change Plan

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...

GuruFocus.com

3 months ago

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ...

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript

Motley Fool

3 months ago

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript

MT Newswires

3 months ago

Amarin Plans 1-for-20 ADS Ratio Adjustment

Associated Press Finance

3 months ago

Amarin: Q4 Earnings Snapshot

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

GlobeNewswire

3 months ago

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action

GlobeNewswire

3 months ago

Amarin Reports Fourth Quarter Financial Results & Business Update and Announces Important Corporate Action

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

GlobeNewswire

4 months ago

Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

Amarin Receives National Reimbursement for VAZKEPA® in Austria

GlobeNewswire

4 months ago

Amarin Receives National Reimbursement for VAZKEPA® in Austria

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Simply Wall St.

4 months ago

Here's Why We're Not Too Worried About Amarin's (NASDAQ:AMRN) Cash Burn Situation

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

GlobeNewswire

4 months ago

Amarin to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 12, 2025

Amarin Receives National Reimbursement for VAZKEPA® in Italy

GlobeNewswire

6 months ago

Amarin Receives National Reimbursement for VAZKEPA® in Italy

MT Newswires

6 months ago

Amarin Names Peter Fishman as CFO

Amarin Appoints Peter Fishman Chief Financial Officer

GlobeNewswire

6 months ago

Amarin Appoints Peter Fishman Chief Financial Officer

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)

Zacks

7 months ago

After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions

GlobeNewswire

7 months ago

Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...

GuruFocus.com

8 months ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines Amid ...

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Zacks

8 months ago

Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

Motley Fool

8 months ago

Amarin Plc (AMRN) Q3 2024 Earnings Call Transcript

Associated Press Finance

8 months ago

Amarin: Q3 Earnings Snapshot

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For

GuruFocus.com

8 months ago

Amarin Corp PLC (AMRN) Q3 2024 Earnings Report Preview: What To Look For

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

GuruFocus.com

9 months ago

Amarin Corp PLC (AMRN) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...

MT Newswires

9 months ago

Opthea Names Medical Chief, CFO

Amarin Announces Two Upcoming Investor Events

GlobeNewswire

9 months ago

Amarin Announces Two Upcoming Investor Events

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Simply Wall St.

9 months ago

Here's Why We're Not At All Concerned With Amarin's (NASDAQ:AMRN) Cash Burn Situation

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

GlobeNewswire

10 months ago

Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

GlobeNewswire

10 months ago

Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ethyl) REDUCE-IT® Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of Cardiology (ESC) Congress

Exploring 3 Undervalued Small Caps In United States With Insider Action

Simply Wall St.

a year ago

Exploring 3 Undervalued Small Caps In United States With Insider Action

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat

Zacks

a year ago

Amarin (AMRN) Stock Down Despite Q2 Earnings & Revenues Beat

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript

Motley Fool

a year ago

Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

Amarin Reports Second Quarter 2024 Financial Results and Provides Business Update

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Zacks

a year ago

Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price

Simply Wall St.

a year ago

Amarin Corporation plc's (NASDAQ:AMRN) Intrinsic Value Is Potentially 29% Above Its Share Price

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Lower Premarket Thursday

MT Newswires

a year ago

Amarin Says Vazkepa Secures National Reimbursement in Portugal

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

GlobeNewswire

a year ago

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal

Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024

GlobeNewswire

a year ago

Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024

MT Newswires

a year ago

Amarin Commercial Partner in China Receives Regulatory Approval for Heart Drug Vascepa

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

GlobeNewswire

a year ago

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise Tuesday Afternoon

MT Newswires

a year ago

Sector Update: Health Care

MT Newswires

a year ago

Update: Amarin Shares Fall After CEO Resignation

MT Newswires

a year ago

Amarin Names Aaron Berg as Chief Executive Officer

Amarin Board of Directors Announces CEO Transition

GlobeNewswire

a year ago

Amarin Board of Directors Announces CEO Transition

MT Newswires

a year ago

Amarin Says Greece Approves Vazkepa for National Reimbursement; Signs Commercialization Agreement With Vianex

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.

GlobeNewswire

a year ago

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A.

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire

a year ago

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Insider Monkey

a year ago

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Amarin First Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

Amarin First Quarter 2024 Earnings: EPS Beats Expectations

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Zacks

a year ago

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

Motley Fool

a year ago

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus

GuruFocus.com

a year ago

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges with Strategic Focus

Associated Press Finance

a year ago

Amarin: Q1 Earnings Snapshot

Amarin Reports First Quarter 2024 Business Update and Financial Results

GlobeNewswire

a year ago

Amarin Reports First Quarter 2024 Business Update and Financial Results

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

GlobeNewswire

a year ago

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

Amarin Announces Results of Annual General Meeting of Shareholders

GlobeNewswire

a year ago

Amarin Announces Results of Annual General Meeting of Shareholders

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

GlobeNewswire

a year ago

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

GlobeNewswire

a year ago

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

CNW Group

a year ago

New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

GlobeNewswire

a year ago

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe

Zacks

a year ago

Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe

Why Amarin Stock Was Rocketing Higher on Wednesday

Motley Fool

a year ago

Why Amarin Stock Was Rocketing Higher on Wednesday

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

GlobeNewswire

a year ago

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

GlobeNewswire

a year ago

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Amarin Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

a year ago

Amarin Full Year 2023 Earnings: Beats Expectations

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts

Simply Wall St.

a year ago

Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Zacks

a year ago

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

Motley Fool

a year ago

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

Associated Press Finance

a year ago

Amarin: Q4 Earnings Snapshot

Share on Social Networks: